Global X HealthTech ETF (NASDAQ:HEAL – Get Free Report) was the target of a large decrease in short interest during the month of June. As of June 30th, there was short interest totaling 13,534 shares, a decrease of 64.0% from the June 15th total of 37,633 shares. Based on an average daily volume of 8,169 shares, the short-interest ratio is currently 1.7 days. Currently, 1.3% of the shares of the stock are short sold.
Global X HealthTech ETF Price Performance
Shares of Global X HealthTech ETF stock traded up $0.34 during trading on Wednesday, reaching $28.44. 3,161 shares of the stock traded hands, compared to its average volume of 11,034. Global X HealthTech ETF has a 52-week low of $23.00 and a 52-week high of $33.59. The business has a fifty day simple moving average of $26.14 and a two-hundred day simple moving average of $26.58. The company has a market capitalization of $30.15 million, a price-to-earnings ratio of 42.80 and a beta of 1.10.
Hedge Funds Weigh In On Global X HealthTech ETF
Institutional investors have recently added to or reduced their stakes in the company. Daiwa Securities Group Inc. bought a new position in shares of Global X HealthTech ETF during the 3rd quarter valued at approximately $11,239,000. WT Wealth Management increased its position in Global X HealthTech ETF by 14.7% in the first quarter. WT Wealth Management now owns 101,116 shares of the company’s stock worth $2,409,000 after purchasing an additional 12,945 shares during the last quarter. Flow Traders U.S. LLC purchased a new stake in Global X HealthTech ETF during the third quarter valued at $368,000. Raymond James Financial Inc. purchased a new stake in Global X HealthTech ETF during the third quarter valued at $274,000. Finally, Citadel Advisors LLC bought a new position in Global X HealthTech ETF during the third quarter valued at $216,000.
About Global X HealthTech ETF
An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.
Featured Stories
- Five stocks we like better than Global X HealthTech ETF
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
- Why ASML’s AI Monopoly Is Still Getting Stronger
- Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings
Receive News & Ratings for Global X HealthTech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global X HealthTech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
